Physician profile
Thomas Rechtschaffen
NPI 1831125913
$52,951.29
in general payments reported to CMS, 2019-2025
57 companies · $6,514 in 2025
The $6,514 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,436 · 2020: $7,287 · 2021: $7,007 · 2022: $6,937 · 2023: $7,000 · 2024: $13K · 2025: $6,514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $9,246 · Honoraria: $1,200 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,638.44 |
| Food and Beverage | $9,246.14 |
| Honoraria | $1,200.00 |
| Education | $199.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $29,034.72 | 2019-2025 | Erleada, Akeega, Balversa |
| Johnson & Johnson Health Care Systems INC. | $3,750.00 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $2,331.37 | 2019-2025 | |
| Astellas Pharma US INC | $1,801.60 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Urogen Pharma, INC. | $1,465.92 | 2021-2025 | Jelmyto |
| Medtronic, INC. | $1,219.61 | 2021-2025 | Nuro, Interstim, Altaviva |
| Procept Biorobotics Corporation | $1,194.13 | 2022-2025 | Aquabeam Robotic System |
| Dendreon Pharmaceuticals LLC | $1,189.76 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $1,148.69 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $924.18 | 2019-2024 | Edex, Aveed, Xiaflex |
| Pfizer INC. | $911.70 | 2019-2025 | |
| Antares Pharma, INC. | $712.26 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Teleflex LLC | $495.53 | 2023-2025 | Urolift |
| Coloplast Corp | $485.90 | 2019-2025 | Saffron |
| Urovant Sciences INC | $475.35 | 2021-2022 |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $465.95 | 2023-2025 | Pylarify |
| Axonics, INC. | $441.46 | 2022-2024 | Bulkamid, Axonics |
| Neotract INC. | $377.54 | 2019 | |
| Abbvie INC. | $366.27 | 2021-2025 | |
| Edap Technomed INC | $360.00 | 2023-2024 | |
| Endo USA, INC. | $352.12 | 2024-2025 | Xiaflex, Aveed, Edex |
| Acerus Pharmaceuticals Corporation | $350.97 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $290.79 | 2020-2025 | Lynparza, Keytruda, Keytruda Qlex |
| Myovant Sciences INC. | $275.10 | 2021-2022 | |
| Medtronic USA, INC. | $233.06 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $224.91 | 2021-2025 | Prolaris, Precisetumor |
| Ferring Pharmaceuticals INC. | $202.88 | 2019-2025 | Adstiladrin |
| Kerecis Limited | $194.22 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Aytu Biopharma, INC. | $165.03 | 2019-2020 | |
| Boston Scientific Corporation | $152.80 | 2020-2025 | Ams 700 Cxr Rte Kit, General - Erectile Dysfunction, Bulkamid |
| Allergan, INC. | $129.32 | 2019-2021 | |
| Blue Earth Diagnostics | $114.16 | 2019-2025 | Posluma |
| Tolmar, INC. | $109.40 | 2024-2025 | Jatenzo, Eligard |
| Clarus Therapeutics INC. | $106.90 | 2021 | |
| Accord Healthcare, INC. | $88.51 | 2023-2025 | |
| Tolmar Pharmaceuticals, INC. | $85.76 | 2019 | |
| Amgen INC. | $77.02 | 2019-2022 | |
| Histosonics, INC. | $65.42 | 2025 | |
| Koelis INC. | $58.29 | 2023 | |
| Sun Pharmaceutical Industries INC. | $56.40 | 2022-2025 | |
| Immunitybio, INC. | $55.06 | 2025 | |
| Lantheus Medical Imaging, INC. | $50.97 | 2024 | |
| Verity Pharmaceuticals INC. | $43.64 | 2025 | Trelstar |
| Laborie Medical Technologies Corp. | $40.43 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Halozyme INC | $36.80 | 2023 | |
| Dentsply Ih Ab | $29.47 | 2024 | Lofric |
| Telix Pharmaceuticals | $26.76 | 2022 | |
| Alnylam Pharmaceuticals INC. | $22.71 | 2021 | |
| Photocure INC | $21.03 | 2022 | |
| 180 Medical, INC. | $20.72 | 2021 | |
| Terumo Medical Corporation | $19.95 | 2025 | Glidewire |
| Cook Medical LLC | $19.61 | 2024 | Litho 150, Cook |
| Olympus America INC. | $19.07 | 2022 | |
| Alfasigma USA, INC. | $17.03 | 2021 | |
| Dentsply Ih INC. | $15.40 | 2021 | |
| Calyxo, INC. | $14.49 | 2025 | Cvac Aspiration System |
| C. R. Bard, INC. & Subsidiaries | $13.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Rechtschaffen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.